| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/29/2003 | EP1278820A1 Reflective disc assay devices, systems and methods |
| 01/29/2003 | EP1278803A2 Sulfonated 8,9]benzophenoxazine dyes and the use of their labelled conjugates |
| 01/29/2003 | EP1278777A2 G protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 01/29/2003 | EP1278776A2 Isolated human transporter proteins, nucleic acids and uses thereof |
| 01/29/2003 | EP1278775A2 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/29/2003 | EP1278774A2 Human g-protein coupled receptors |
| 01/29/2003 | EP1278773A2 Selectable cell surface marker genes |
| 01/29/2003 | EP1278771A2 A method for activating only the vascular endothelial growth factor receptor-3 and uses thereof |
| 01/29/2003 | EP1278770A1 Human wingless-like gene |
| 01/29/2003 | EP1278766A2 Polynucleotides for diagnosing mammary gland cancer |
| 01/29/2003 | EP1278760A1 Tag library compounds, compositions, kits and methods of use |
| 01/29/2003 | EP1278535A2 Uses of tgap7 for the modulation of leucocyte activation |
| 01/29/2003 | EP1244681A4 Metal cluster containing nucleotides and nucleic acids, and intermediates therefor |
| 01/29/2003 | EP1226571A4 System and method for programmable illumination pattern generation |
| 01/29/2003 | EP1104491A4 Methods and systems for sequencing dna by distinguishing the decay times of fluorescent probes |
| 01/29/2003 | EP0904397A4 A method for detection of prostate specific antigen used in monitoring and diagnosis of prostate cancer |
| 01/29/2003 | EP0857220B1 Sequence modification of oligonucleotide primers to manipulate non-templated nucleotide addition |
| 01/29/2003 | EP0842184B1 Nucleic acid isolation |
| 01/29/2003 | EP0832297B1 Method for identifying compounds modulating bone growth |
| 01/29/2003 | EP0828483B1 Use of tropolone derivatives as inhibitors of the enzyme inositol monophosphatase |
| 01/29/2003 | EP0648222B1 Methods of single nucleotide primer extension to detect specific alleles and kits therefor |
| 01/29/2003 | EP0592626B1 METHODS TO CLONE mRNA |
| 01/29/2003 | CN1394281A Reagent test strip for analyte determination |
| 01/29/2003 | CN1394278A Electrochemical test strip for use in analyte determination |
| 01/29/2003 | CN1394235A Method for detection of pathogenic organisms |
| 01/29/2003 | CN1394234A System, method and apparatus for transgenic and targeted mutagenesis screening |
| 01/29/2003 | CN1393567A Preparing process and usage of oligonucleotide gene chip for testing medicine resistance of hepatitis B virus |
| 01/29/2003 | CN1393566A Reagent for determining germplasm of kelp and its application method |
| 01/29/2003 | CN1393557A Polypeptide-human protein-14.08 containing peptidyl-prolyl cis-trans isomerase characteristic sequence fragment and polynucleotide for coding it |
| 01/29/2003 | CN1393555A Polypeptide-proteasome-61.82 and polynucleotide for coding it |
| 01/29/2003 | CN1393554A Polypeptide-human protein-9.57 containing glycosylhydrolase family 17 characteristic sequence fragment and polynucleotide for coding it |
| 01/29/2003 | CN1393553A Polypeptide-human phosphatidase-30.47 and polynucleotide for coding it |
| 01/29/2003 | CN1393552A Polypeptide-human myotonic dystrophy protein kinase -61.27 and polynucleotide for coding it |
| 01/29/2003 | CN1393550A Polypeptide-human respiratory chain CoQ oxide-reductase-11.22 and polynucleotide for coding it |
| 01/29/2003 | CN1393548A Polypeptide-human protein-13.2 containing site specific recombinase characteristic sequence fragrant and polynucleotide for coding it |
| 01/29/2003 | CN1393547A Polypeptide-human protein-9.35 containing cytosine specific DNA methylase characteristic sequence fragment and polynucleotide for coding it |
| 01/29/2003 | CN1100267C Blood glucose strip having reduced sensitivity to hematocrit |
| 01/29/2003 | CN1100266C Luciferase labelling method and labelled products |
| 01/29/2003 | CN1100258C Method of assaying specimen substance by controlling dose of chemiluminescence |
| 01/29/2003 | CN1100150C Taq immobilized enzyme carrier single person detecting tube of polymerase chain reaction detecting reagent box |
| 01/29/2003 | CN1100149C Viroid testing method of fusoid tuber of potato |
| 01/29/2003 | CN1100148C Identifying method of bacteria and fungus and its test card |
| 01/29/2003 | CA2417579A1 Method of proliferating natural killer cells |
| 01/28/2003 | US6512105 Methods for making oligonucleotide probes for the detection and/or quantitation of non-viral organisms |
| 01/28/2003 | US6512104 Interleukin-1β converting enzyme like cysteine protease |
| 01/28/2003 | US6512098 Chemically modified proteins with a carbohydrate moiety |
| 01/28/2003 | US6512091 BRCA1 mutations, PCR primers and hybridization probes used in nucleic acid-based methods for diagnosis; presence or absence of the translation product of BRCA1 alleles |
| 01/28/2003 | US6511853 Microfluidic serial analysis systems are optimized by maximizing the proximity and speed with which multiple different samples may be serially introduced |
| 01/28/2003 | US6511849 Reproducible and rapid manner; ink jet used to deposit small drops of liquid on a solid substrate |
| 01/28/2003 | US6511840 Share structural similarity with animal kinases, including, but not limited to myosin kinases |
| 01/28/2003 | US6511836 Method of improving the production of biomass or a desired product from a cell |
| 01/28/2003 | US6511831 Electrical integrated nucleic acid isolation, purification and detection |
| 01/28/2003 | US6511825 Cell signaling polypeptides and nucleic acids |
| 01/28/2003 | US6511823 Novel DNA and amino acid sequences; expression vectors and host cells useful in a method for production of the HBNF protein |
| 01/28/2003 | US6511819 Rapid coliform detection system |
| 01/28/2003 | US6511818 Using checkpoint gene-defective (genes that regulate mitosis) cells; potential therapeutic agents are screened for the ability to cause DNA accumulation or cell death in a checkpoint gene-defective human cell |
| 01/28/2003 | US6511817 Detecting oscillations of extracellular voltage; indication of the presence of psychoactive material in the candidate sample |
| 01/28/2003 | US6511813 Identifying compound which inhibits peptide bond reaction of a complex formed by interaction of EFP, N-formyl methionyl-tRNA, 30S subunit, 50S subunit, an mRNA containing AUG sequence, initiation factors 1, 2, 3, and peptide bond donor |
| 01/28/2003 | US6511812 Adding denatured and/or purified bacterial enzyme; recombinant antigens expressed as fusion proteins with a bacterial enzyme which is CKS |
| 01/28/2003 | US6511811 Protein kinase C antagonist related to insulin receptor |
| 01/28/2003 | US6511810 Polynucleotide sequence assay |
| 01/28/2003 | US6511809 Screening for preferential particle in sample; obtain sample of nucleotide sequences, incubate with reporter complex, amplify, monitor sample for signal |
| 01/28/2003 | US6511808 Generating transcriptional control proteins; obtain nucleotide sequences, screen for reguatory sequences, generate transcription control protein, |
| 01/28/2003 | US6511807 Carbohydrate ligand that specifically binds to a leczyme; nucleic acid sequence encoding a nonclassical MHC class I heavy chain; ability to associate with a beta 2 microglobulin; major histocompatibility complex transplantation molecules |
| 01/28/2003 | US6511806 Methods for cancer prognosis and diagnosis |
| 01/28/2003 | US6511805 Methods for detecting papillomavirus DNA in blood plasma and serum |
| 01/28/2003 | US6511804 Selective assay for determining the identity of live microorganisms in a mixed culture |
| 01/28/2003 | US6511803 Replica amplification of nucleic acid arrays |
| 01/28/2003 | US6511802 Solid phase selection of differentially expressed genes |
| 01/28/2003 | US6511801 HIV-1 group O strain gp160 env precursor protein comprising the amino acid sequence of SEQ ID NO:100 |
| 01/28/2003 | US6511799 Increased expression of CDX2 gene product indicates candidate drug for cancers with mutant adenomatous polyposis coli alleles; catenin/TCF regulated transcription (CRT) is absent in RKO colorectal cancer cell line; CDX2 mRNA and CDX2 protein |
| 01/28/2003 | US6511665 Antibodies to interleukin-1 receptors |
| 01/28/2003 | US6511664 Antiinflammatory |
| 01/28/2003 | US6511592 Measuring a current associated with enzyme-catalyzed oxidation withpentachlorophenol hydroxylase |
| 01/28/2003 | CA2253654C Novel nucleoside analogs with polycyclic aromatic groups attached, methods of synthesis and uses therefor |
| 01/27/2003 | CA2391642A1 Identification and use of molecules implicated in pain |
| 01/27/2003 | CA2391219A1 Identification and use of molecules implicated in pain |
| 01/27/2003 | CA2391216A1 Identification and use of molecules implicated in pain |
| 01/27/2003 | CA2391112A1 Identification and use of molecules implicated in pain |
| 01/24/2003 | WO2002008456A2 Method for identifying metastatic tumor cells |
| 01/24/2003 | CA2416697A1 Method for identifying metastasizing tumor cells |
| 01/23/2003 | WO2003006996A2 Natural ligand of gpcr chemr23 and uses thereof |
| 01/23/2003 | WO2003006995A2 Method for identifying substances which modulate interleukin 4 (il-4) signaling |
| 01/23/2003 | WO2003006991A1 HADHs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 01/23/2003 | WO2003006990A1 Modifiers of the p21 pathway and methods of use |
| 01/23/2003 | WO2003006988A1 Cardiovascular safety assay |
| 01/23/2003 | WO2003006987A1 Methods and compositions for determining enzymatic activity and specificity of methyltransferases |
| 01/23/2003 | WO2003006985A1 Examination method for diagnosing rheumatoid arthritis and reagent for examination diagnosis |
| 01/23/2003 | WO2003006973A1 System and method for differential protein expression and a diagnostic biomarker discovery system and method using same |
| 01/23/2003 | WO2003006956A2 Cell enumeration |
| 01/23/2003 | WO2003006950A2 Cells of the cardiomyocyte lineage produced from human pluripotent stem cells |
| 01/23/2003 | WO2003006948A2 Surface plasmon resonance imaging of micro-arrays |
| 01/23/2003 | WO2003006713A1 Electrode compositions and configurations for electrochemical bioreactor systems |
| 01/23/2003 | WO2003006692A1 Internal calibration standards for electrophoretic analyses |
| 01/23/2003 | WO2003006690A1 Use of urokinase gene amplification as a marker |
| 01/23/2003 | WO2003006687A2 Novel target genes for diseases of the heart |
| 01/23/2003 | WO2003006686A1 Bioassay for myostatin |
| 01/23/2003 | WO2003006685A1 Method for obtaining a titrated preparation of algae and resulting titrated preparations |
| 01/23/2003 | WO2003006684A2 Device and method for detecting photosynthesis inhibition |
| 01/23/2003 | WO2003006683A1 Suppression of non-biological motion |